Agile Therapeutics Ownership | Who Owns Agile Therapeutics?
Agile Therapeutics Ownership Summary
100.00% retail investors. SSgA U.S. Extended Market Index Class I is the top mutual fund, with 0.00% of its assets in Agile Therapeutics shares.
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 1 | - | 10 | - | - | - | 1 | - | - | - |
| Mar 31, 2022 | 35 | -25.53% | 40,559,779 | 7.73% | 32 | 2.16% | 16 | -27.27% | 7 | -46.15% |
| Dec 31, 2021 | 47 | -12.96% | 37,651,153 | 18.45% | 38 | 3.62% | 22 | 69.23% | 13 | -40.91% |
| Sep 30, 2021 | 54 | -25.00% | 31,787,149 | -7.56% | 32 | 1.99% | 13 | -60.61% | 22 | -12.00% |
| Jun 30, 2021 | 72 | -10.00% | 34,385,876 | -10.17% | 40 | 1.99% | 33 | - | 25 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| SSgA U.S. Extended Market Index Class I | 15.00 | 0.00% | - |
| NT US Market Cap Idx Fd - L | 5.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 26, 2022 | ALTOMARI ALFRED | Chief Executive Officer | Buy | $22.50K |
| Oct 13, 2021 | PERCEPTIVE ADVISORS LLC | - | Buy | $2.28M |
| Oct 13, 2021 | PERCEPTIVE ADVISORS LLC | - | Buy | $4.87M |
| Oct 13, 2021 | Reilly Dennis | Chief Financial Officer | Buy | $25.00K |
| Oct 13, 2021 | Reilly Dennis | Chief Financial Officer | Buy | $50.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | - |
| 2022 Q4 | - | - |
AGRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools